Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia-Reference-Cited by-同舟云学术

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia

Published:2017-01 Issue:1 Volume:31 Page:73-75
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Devanand Davangere P.,Pelton Gregory H.,D’Antonio Kristina,Strickler Jesse G.,Kreisl William C.,Noble James,Marder Karen,Skomorowsky Anne,Huey Edward D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference15 articles.

1. Delusions and hallucinations are associated with worse outcome in Alzheimer Disease;Scarmeas;Arch Neurol,2005

2. Disruptive behavior as a predictor in Alzheimer disease;Scarmeas;Arch Neurol,2007

3. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia;Rascovsky;Brain,2011

4. Caregiver burden in frontotemporal degeneration and corticobasal syndrome;Armstrong;Dement Geriatr Cogn Disord,2013

5. A randomized, placebo-controlled, dosecomparison trial of haloperidol treatment for psychosis and disruptive behaviors in Alzheimer’s disease;Devanand;Am J Psychiatry,1998

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs;Frontiers in Pharmacology;2024-07-11

2. Lithium management of periodic mood fluctuations in behavioural frontotemporal dementia: a case report;Frontiers in Psychiatry;2024-01-08

3. Neuropsychiatric Symptoms (NPS) and Neurocognitive Disorders;Age-Adjusted Psychiatric Treatment for the Older Patient;2024

4. Major Neurocognitive Disorders Due to Frontotemporal Disease;Treatment of Psychiatric Disorders Among Older Adults;2024

5. Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease;Molecular Neurobiology;2023-12-08